US Stock MarketDetailed Quotes

PHAT Phathom Pharmaceuticals

Watchlist
  • 10.405
  • +0.735+7.60%
Trading May 14 10:44 ET
609.06MMarket Cap-2332P/E (TTM)

Phathom Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
1.91M
682K
682K
0
0
0
0
0
0
0
Operating revenue
--1.91M
--682K
--682K
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
426K
167K
0
0
Gross profit
1.49M
515K
0
0
Operating expense
137.52%71.44M
-2.68%167.83M
50.92%70.39M
-16.15%35.66M
-30.12%31.7M
-20.65%30.08M
27.66%172.44M
41.17%46.64M
28.34%42.53M
28.44%45.36M
Selling and administrative expenses
233.42%62.01M
16.76%117.93M
85.68%57M
-0.48%23.4M
-28.67%18.94M
-8.14%18.6M
60.98%101M
57.51%30.7M
42.23%23.51M
93.47%26.55M
Research and development costs
-17.85%9.43M
-30.15%49.9M
-16.00%13.39M
-35.53%12.26M
-32.16%12.76M
-35.00%11.48M
-1.24%71.44M
17.67%15.95M
14.52%19.02M
-12.88%18.82M
Operating profit
-132.58%-69.95M
2.97%-167.31M
-49.81%-69.88M
16.15%-35.66M
30.12%-31.7M
20.65%-30.08M
-27.66%-172.44M
-41.17%-46.64M
-28.34%-42.53M
-28.44%-45.36M
Net non-operating interest income expense
-65.72%-12.86M
-35.43%-34.09M
-16.43%-9.68M
13.61%-7.39M
-66.82%-9.27M
-181.87%-7.76M
-273.10%-25.17M
-200.29%-8.32M
-478.94%-8.55M
-346.90%-5.56M
Non-operating interest income
195.41%4.31M
269.42%7.88M
160.14%3.35M
274.66%2.72M
210.71%348K
20,757.14%1.46M
5,100.00%2.13M
21,350.00%1.29M
8,975.00%726K
761.54%112K
Non-operating interest expense
86.26%17.17M
53.70%41.97M
35.69%13.03M
8.95%10.11M
69.67%9.62M
234.07%9.22M
302.25%27.31M
246.02%9.6M
524.71%9.28M
351.19%5.67M
Other net income (expense)
-315.00%-43K
-70.91%-188K
84.44%-14K
-1,690.91%-197K
250.00%3K
385.71%20K
94.65%-110K
-429.41%-90K
99.46%-11K
-120.00%-2K
Other non- operating income (expenses)
-315.00%-43K
-70.91%-188K
84.44%-14K
-1,690.91%-197K
250.00%3K
385.71%20K
94.65%-110K
-429.41%-90K
99.46%-11K
-120.00%-2K
Income before tax
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
-39.36%-51.09M
-39.31%-50.92M
Income tax
Net income
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
-39.36%-51.09M
-39.31%-50.92M
Net income continuous Operations
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
-39.36%-51.09M
-39.31%-50.92M
Minority interest income
Net income attributable to the parent company
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
-39.36%-51.09M
-39.31%-50.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-119.10%-82.85M
-1.96%-201.59M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-37.42%-197.72M
-53.65%-55.05M
-39.36%-51.09M
-39.31%-50.92M
Basic earnings per share
-59.55%-1.42
22.18%-3.93
-9.02%-1.45
42.42%-0.76
36.84%-0.84
16.82%-0.89
-29.82%-5.05
-40.00%-1.33
-34.69%-1.32
-33.00%-1.33
Diluted earnings per share
-59.55%-1.42
22.18%-3.93
-9.02%-1.45
42.42%-0.76
36.84%-0.84
16.82%-0.89
-29.82%-5.05
-40.00%-1.33
-34.69%-1.32
-33.00%-1.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 1.91M682K682K0000000
Operating revenue --1.91M--682K--682K--0--0--0--0--0--0--0
Cost of revenue 426K167K00
Gross profit 1.49M515K00
Operating expense 137.52%71.44M-2.68%167.83M50.92%70.39M-16.15%35.66M-30.12%31.7M-20.65%30.08M27.66%172.44M41.17%46.64M28.34%42.53M28.44%45.36M
Selling and administrative expenses 233.42%62.01M16.76%117.93M85.68%57M-0.48%23.4M-28.67%18.94M-8.14%18.6M60.98%101M57.51%30.7M42.23%23.51M93.47%26.55M
Research and development costs -17.85%9.43M-30.15%49.9M-16.00%13.39M-35.53%12.26M-32.16%12.76M-35.00%11.48M-1.24%71.44M17.67%15.95M14.52%19.02M-12.88%18.82M
Operating profit -132.58%-69.95M2.97%-167.31M-49.81%-69.88M16.15%-35.66M30.12%-31.7M20.65%-30.08M-27.66%-172.44M-41.17%-46.64M-28.34%-42.53M-28.44%-45.36M
Net non-operating interest income expense -65.72%-12.86M-35.43%-34.09M-16.43%-9.68M13.61%-7.39M-66.82%-9.27M-181.87%-7.76M-273.10%-25.17M-200.29%-8.32M-478.94%-8.55M-346.90%-5.56M
Non-operating interest income 195.41%4.31M269.42%7.88M160.14%3.35M274.66%2.72M210.71%348K20,757.14%1.46M5,100.00%2.13M21,350.00%1.29M8,975.00%726K761.54%112K
Non-operating interest expense 86.26%17.17M53.70%41.97M35.69%13.03M8.95%10.11M69.67%9.62M234.07%9.22M302.25%27.31M246.02%9.6M524.71%9.28M351.19%5.67M
Other net income (expense) -315.00%-43K-70.91%-188K84.44%-14K-1,690.91%-197K250.00%3K385.71%20K94.65%-110K-429.41%-90K99.46%-11K-120.00%-2K
Other non- operating income (expenses) -315.00%-43K-70.91%-188K84.44%-14K-1,690.91%-197K250.00%3K385.71%20K94.65%-110K-429.41%-90K99.46%-11K-120.00%-2K
Income before tax -119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M-39.36%-51.09M-39.31%-50.92M
Income tax
Net income -119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M-39.36%-51.09M-39.31%-50.92M
Net income continuous Operations -119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M-39.36%-51.09M-39.31%-50.92M
Minority interest income
Net income attributable to the parent company -119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M-39.36%-51.09M-39.31%-50.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -119.10%-82.85M-1.96%-201.59M-44.55%-79.57M15.36%-43.24M19.55%-40.97M7.01%-37.81M-37.42%-197.72M-53.65%-55.05M-39.36%-51.09M-39.31%-50.92M
Basic earnings per share -59.55%-1.4222.18%-3.93-9.02%-1.4542.42%-0.7636.84%-0.8416.82%-0.89-29.82%-5.05-40.00%-1.33-34.69%-1.32-33.00%-1.33
Diluted earnings per share -59.55%-1.4222.18%-3.93-9.02%-1.4542.42%-0.7636.84%-0.8416.82%-0.89-29.82%-5.05-40.00%-1.33-34.69%-1.32-33.00%-1.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg